kaiser semaglutide reddit California is ending coverage for weight loss drugs, despite TrumpRx Telehealth booms on surging GLP-1

A randomized clinical trial published in May 2026 in The Lancet investigated whether semaglutide, a GLP-1 peptide that acts as a GLP-1 receptor agonist and is approved for obesity treatment, was associated with changes in alcohol consumption among adults living with both obesity and alcohol use disorder

25.) More anecdotally, she continued, experts like Dr

Why GLP-1 Medications Can Make Symptoms Worse GLP-1 medications can amplify these issues in a few ways: Changes in appetite and eating patterns Increased sensitivity to fullness and pressure Altered breathing patterns due to discomfort Increased abdominal guarding or bracing When breathing mechanics shift and the diaphragm is not moving well, pressure is often redirected outward into the abdomen instead of being managed efficiently within the system

Neuroendocrinology 83 (56), 360370 (2006).doi: 10.1159/000095548